Relative safety of meloxicam in NSAID-intolerant patients

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 53, Issue 12, 1998, Pages 1231-1233

  Kosnik M ^a   Music E ^b   Matjaz F ^b   Suskovic S ^b  

^a UNIVERSITY CLINIC OF RESPIRATORY AND ALLERGIC DISEASES   (Slovenia)

^b NONE

Author keywords

Challenge tests; Intolerance; Meloxicam; NSAID

Indexed keywords

ACETYLSALICYLIC ACID; MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ALLERGY; ANGIONEUROTIC EDEMA; CLINICAL ARTICLE; DRUG SAFETY; DRUG TOLERANCE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SHORT SURVEY; URTICARIA;

EID: 0032414306     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1998.tb03854.x     Document Type: Short Survey

References (6)

1. Szczeklik A. The cycloox̌ygenase theory of aspirin-induced asthma. Eur Respir J 1990;3:588-93.
2. Vane JR. Introduction: mechanism of action of NSAID. Br J Rheumatol 1996;35 Suppl 1:1-3.
3. Patoia L, Santucci L, Furno P. et al. A 4-week, double blind, parallel-group study to compare the gastrointestinal effects of meloxicam 7.5 mg, meloxicam 15 mg, piroxicam 20 mg and placebo by means of faecal blood loss, endoscopy and symptoms evaluation in healthy volunteers. BrJ Rheumatol 1996;35 Suppl 1:61-7.
4. 2 synthesis in healthy volunteers. Br J Rheumatol 1996;35 Suppl 1:220.
5. Dahlen B, Zetterström O. Comparison of bronchial and per oral provocation with aspirin in aspirin sensitive asthmatics. Eur Respir J 1990;3:527-34.
6. Phillips GD, Ford R, Holgate ST. Inhaled lysine-aspirin as a bronchoprovocation procedure in aspirin-sensitive asthma: its repeatability, absence of a late-phase reaction, and the role of histamine. J Allergy Clin Immunol 1989;84:232-41.